Largest biotech by total liabilities

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

CG Oncology has the lowest figure of the 24 biotech ranked by total liabilities, at CHF 32.9M, followed by Immunovant (CHF 88M) and Krystal Biotech (CHF 96.3M). Figures as of 18 Nov 2026, 15:42 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
CG OncologyCHF 32.9M
Median
CHF 592.6M
Combined market value
CHF 705.8B
Countries
5

Market values as of .

Largest biotech by total liabilities
#CompanyTotal liabilities ↑Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health CareCHF 32.9MCHF 6BCHF 67.13 0.91% up 85% up United States
2ImmunovantIMVT · Health CareCHF 88MCHF 5.9BCHF 28.27 1.01% up 43% up United States
3Krystal BiotechKRYS · Health CareCHF 96.3MCHF 7.6BCHF 256.09 1.79% up 46% up United States
4Scholar Rock HoldingSRRK · Health CareCHF 133.8MCHF 4.8BCHF 39.55 4.11% up 14% up United States
5Kymera TherapeuticsKYMR · Health CareCHF 137.5MCHF 8.7BCHF 101.99 0.41% down 87% up United States
6Twist BioscienceTWST · Health CareCHF 142.3MCHF 6.5BCHF 95.52 1.21% up 340% up United States
7Kodiak SciencesKOD · Health CareCHF 163.6MCHF 5.3BCHF 81.49 0.10% down 396% up United States
8Adaptive BiotechnologiesADPT · Health CareCHF 242.5MCHF 3.9BCHF 23.97 0.18% down 88% up United States
9VaxcytePCVX · Health CareCHF 267.3MCHF 7.7BCHF 48.62 2.88% down 22% up United States
10CRISPR TherapeuticsCRSP · Health CareCHF 289.4MCHF 3.4BCHF 34.58 2.19% up 21% down Switzerland
11Bio-TechneTECH · Health CareCHF 403.3MCHF 9.6BCHF 61.27 0.11% up 26% up United States
12ExelixisEXEL · Health CareCHF 575.7MCHF 14.1BCHF 57.68 0.07% down 63% up United States
13Revolution MedicinesRVMD · Health CareCHF 609.5MCHF 28.9BCHF 133.80 2.41% down 131% up United States
14RepligenRGEN · Health CareCHF 710.9MCHF 9.1BCHF 143.10 4.70% up 5% up United States
15ImmunityBioIBRX · Health CareCHF 844MCHF 6BCHF 5.60 6.16% up 193% up United States
16argenxARGX · Health CareCHF 1.1BCHF 50.3BCHF 800.45 0.24% up 4% up Belgium
17Neurocrine BiosciencesNBIX · Health CareCHF 1.2BCHF 13.8BCHF 136.17 2.62% down 20% up United States
18Halozyme TherapeuticsHALO · Health CareCHF 2.1BCHF 9.3BCHF 81.23 0.44% up 37% up United States
19QiagenQGEN · Health CareCHF 2.1BCHF 8.6BCHF 41.75 0.41% down 12% up Netherlands
20BioNTechBNTX · Health CareCHF 2.6BCHF 17.5BCHF 70.69 1.15% down 16% down Germany
21ModernaMRNA · Health CareCHF 3.1BCHF 68.6BCHF 169.56 2.71% down 755% up United States
22BiogenBIIB · Health CareCHF 9.4BCHF 30.9BCHF 209.23 1.00% down 49% up United States
23Gilead SciencesGILD · Health CareCHF 30.7BCHF 175.9BCHF 141.80 1.17% down 33% up United States
24AmgenAMGN · Health CareCHF 69BCHF 203.4BCHF 376.05 2.55% down 34% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8427 CHF).

Questions and answers

Which biotech have the lowest total liabilities?

CG Oncology (CHF 32.9M), Immunovant (CHF 88M) and Krystal Biotech (CHF 96.3M) have the lowest total liabilities of the 24 biotech ranked here as of 18 Nov 2026, 15:42 UTC.

How many biotech are in this ranking?

24 are ranked by total liabilities.

What are these biotech worth together?

The 24 biotech ranked by total liabilities have a combined market value of CHF 705.8B as of 18 Nov 2026, 15:42 UTC.

What does ranking by total liabilities measure?

Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.

Cite this page

Funkfolio, “Largest biotech by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-liabilities

Underlying data: Yahoo Finance; SEC EDGAR.